ImClone Systems

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

ImClone Systems topic overview

The analysis highlights Applications, Art and Companies as prominent areas in the source structure around ImClone Systems.

Related topics: 29
Source areas: 6
Connected nodes: 35
Extracted relationships: 8
Related term clusters: 16
Bridge connections: 35

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Insider trading scandal · 14 topics

Overview · 7 topics

Yeda/Aventis/Imclone patent dispute · 5 topics

Carl Icahn acquisition · 1 topics

Compassionate use controversy · 1 topics

Takeover offer from Bristol-Myers Squibb, and subsequent bidding showdown · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded: 1984; 42 years ago (1984)
Industry: Biotechnology company · Pharmaceutical industry
Number of employees: 1,128
Parent: Eli Lilly and Company
Traded as: Nasdaq: IMCL
Type: Subsidiary

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

ImClone Systems

7Biopharmaceutical · Medicine · Oncology

22Cetuximab · Monoclonal antibody · Food and Drug Administration

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Insider trading scandal

Compassionate use controversy

Expanded access

Carl Icahn acquisition

Carl Icahn

Yeda/Aventis/Imclone patent dispute

Takeover offer from Bristol-Myers Squibb, and subsequent bidding showdown

Ramucirumab

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How ImClone Systems connects Entity context

The extracted context around ImClone Systems shows recurring relationship patterns in the source. For example, ImClone Systems → Biotechnology company, Pharmaceutical industry Another extracted example is ImClone Systems → 1984; 42 years ago (1984). Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

Industry · 2

ImClone Systems → Biotechnology company, Pharmaceutical industry

Founded · 1

ImClone Systems → 1984; 42 years ago (1984)

Number of employees · 1

ImClone Systems → 1,128

Parent · 1

ImClone Systems → Eli Lilly and Company

Traded as · 1

ImClone Systems → Nasdaq: IMCL

Type · 1

ImClone Systems → Subsidiary

Website · 1

ImClone Systems → www.imclone.com

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

imclone company lilly erbitux eli waksal 2008 stock use yeda patent offer sold shares cancer years drug fda share research

ImClone Systems relationships Subject–Predicate–Object triples

TTTA extracted 8 structured relationships around ImClone Systems. Examples in this analysis include ImClone Systems → Founded → 1984; 42 years ago (1984) and ImClone Systems → Industry → Biotechnology company. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
ImClone Systems	Founded	1984; 42 years ago (1984)	1.00	infobox
ImClone Systems	Industry	Biotechnology company	1.00	infobox
ImClone Systems	Industry	Pharmaceutical industry	1.00	infobox
ImClone Systems	Number of employees	1,128	1.00	infobox
ImClone Systems	Parent	Eli Lilly and Company	1.00	infobox
ImClone Systems	Traded as	Nasdaq: IMCL	1.00	infobox
ImClone Systems	Type	Subsidiary	1.00	infobox
ImClone Systems	Website	www.imclone.com	1.00	infobox

Related concept clusters Related term clusters

The concept neighborhoods around ImClone Systems bring nearby vocabulary together. In this analysis, examples include Drug, Lilly and Bristol-myers. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

ImClone Systems
- Drug
- Lilly
- Bristol-myers
- Squibb
- Fda
- Share
- Cancer
- Erbitux
- Use
- Yeda
- Failed
- Patent
imclone systems
- Drug
- Lilly
- Bristol-myers
- Squibb
- Fda
- Share
- Cancer
- Erbitux
- Use
- Yeda
- Failed
- Patent
eli lilly and company
- Lilly
- Subsidiary
- Imclone
- Imcl
- Nasdaq
- Eli
- October
- Offer
- Share
- Drug
- Erbitux
- Use
bristol-myers squibb
- Squibb
- Failed
- Drug
- Fda
- Offer
- Share
- Erbitux
- Imclone
- Imcl
- Nasdaq
- Subsidiary
- Approval
carl icahn
- Icahn
- Offer
- Imclone's
- Stock
- Imcl
- Nasdaq
- Subsidiary
- Approval
- Failed
- October
- Announcement
- Bristol-myers
carl icahn acquisition
- Icahn
- Imcl
- Nasdaq
- Subsidiary
- Offer
- Imclone's
- Eli
- Lilly
- Stock
- Approval
- Billion
- Carl
yeda/aventis/imclone patent dispute
- Patent
- Yeda
- Years
- Use
- Drug
- Lilly
- Research
- Bristol-myers
- Squibb
- Fda
- Share
- Company
takeover offer from bristol-myers squibb, and subsequent bidding showdown
- Squibb
- Carl
- Imclone's
- Icahn
- Failed
- Subsidiary
- Bristol-myers
- Drug
- Fda
- Offer
- Share
- Erbitux

Connections between topic areas Semantic bridges

For ImClone Systems, one of the stronger structural bridges in this analysis connects ImClone Systems with Insider trading scandal. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

ImClone Systems — Insider trading scandal · splits 21 ⟂ 15

ImClone Systems — Overview · splits 28 ⟂ 8

ImClone Systems — Yeda/Aventis/Imclone patent dispute · splits 30 ⟂ 6

Map overview Semantic statistics

ImClone Systems

Nodes36

Edges35

Triples8

Avg. degree1.94

Density0.055556

Components1

Source & methodology

TTTA analyzes the structure around ImClone Systems to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Art & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — ImClone Systems · EN edition · Analysis: TopicsToTalkAbout

ImClone Systems: Applications, Art & Companies

ImClone Systems topic overview

What this topic covers Research coverage

Key facts & relationships

Start with your topic. Discover where to go next.

Questions to explore

Explore all related topics Closing gaps

Overview

Insider trading scandal

Compassionate use controversy

Carl Icahn acquisition

Yeda/Aventis/Imclone patent dispute

Takeover offer from Bristol-Myers Squibb, and subsequent bidding showdown

For the semantics nerds

Advanced semantic analysis

How ImClone Systems connects Entity context

ImClone Systems

Top relations

Important terminology

Important terminology

ImClone Systems relationships Subject–Predicate–Object triples

Related concept clusters Related term clusters

Connections between topic areas Semantic bridges

Map overview Semantic statistics

ImClone Systems

Source & methodology